Sfoglia per Soggetto "TRANSITIONAL-CELL CARCINOMA"
Items 1-3 di 3
-
In vitro biocompatibility between mitomycin-C (MMC) and bacillus Calmette-Guerin (BCG)
(2006)Background: Mitomycin-C (MMC) and bacillus Calmette-Guerin (BCG) intravesical instillations are widely and effectively used as adjuvant treatment for superficial bladder cancer. In an attempt to improve the efficacy of ... -
Molecular Pathogenesis of Non Muscle-Invasive Bladder Cancer: Implications for Novel Targeted Therapies
(2011)Approximately 70% to 80% of patients with urothelial carcinomas of the bladder are initially diagnosed with non-muscle invasive disease. Superficial, non-muscle invasive bladder cancers (NMIBCs) are managed with cystoscopic ... -
Systemic therapy of metastatic bladder cancer in the molecular era: current status and future promise
(2010)Importance of the field: Platinum-based chemotherapy is considered the standard-of-care first-line therapy for metastatic bladder cancer. Despite the initial high response rate, the vast majority of patients eventually ...